A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis

PURPOSE: FASTR was designed to provide a compact treatment course for high-risk prostate cancer patients but was discontinued because of excess toxicity. We present the results of FASTR-2, which used a lower dose to the prostate (35 Gy vs 40 Gy), smaller posterior PTV margin (4 mm vs 5 mm) and omitt...

Descripción completa

Detalles Bibliográficos
Autores principales: Callan, Laura, Bauman, Glenn, Chen, Jeff, Lock, Michael, Sexton, Tracy, D'Souza, David, Rodrigues, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817718/
https://www.ncbi.nlm.nih.gov/pubmed/31681864
http://dx.doi.org/10.1016/j.adro.2019.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817718/
https://www.ncbi.nlm.nih.gov/pubmed/31681864
http://dx.doi.org/10.1016/j.adro.2019.07.007

Ejemplares similares